NLRX1 suppresses tumorigenesis and attenuates histiocytic sarcoma through the negative regulation of NF-κB signaling.
Coutermarsh-Ott S, Simmons A, Capria V, LeRoith T, Wilson JE, Heid B, Philipson CW, Qin Q, Hontecillas-Magarzo R, Bassaganya-Riera J, Ting JP, Dervisis N, Allen IC.
Coutermarsh-Ott S, et al. Among authors: allen ic.
Oncotarget. 2016 May 31;7(22):33096-110. doi: 10.18632/oncotarget.8861.
Oncotarget. 2016.
PMID: 27105514
Free PMC article.